Peripheral Protein Biomarker changes following Selective Inhibition of Janus Kinase 1 (JAK1) by Filgotinib in Adults with Moderately-to-severely Active Rheumatoid Arthritis with Prior Inadequate Response to Methotrexate (FINCH1)
Main Authors: | , , , , , |
---|---|
Format: | Conference item |
Language: | English |
Published: |
BMJ Publishing Group
2020
|
Summary: |
---|